ACM

ADAR1 Capital Management Portfolio holdings

AUM $1.66B
1-Year Est. Return 340.85%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+340.85%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.66B
AUM Growth
+$327M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
329
New
Increased
Reduced
Closed

Top Buys

1 +$40.1M
2 +$37.1M
3 +$36.2M
4
INSP icon
Inspire Medical Systems
INSP
+$27.3M
5
VIR icon
Vir Biotechnology
VIR
+$21.9M

Top Sells

1 +$39.4M
2 +$17.3M
3 +$13.2M
4
FULC icon
Fulcrum Therapeutics
FULC
+$10.4M
5
ABUS icon
Arbutus Biopharma
ABUS
+$9.98M

Sector Composition

1 Healthcare 90.27%
2 Financials 1.54%
3 Technology 0.08%
4 Industrials 0.08%
5 Materials 0.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVDL
301
DELISTED
Avadel Pharmaceuticals
AVDL
-150,532
AZN icon
302
AstraZeneca
AZN
$288B
-9,000
CDTX
303
DELISTED
Cidara Therapeutics
CDTX
-59,677
DVAX
304
DELISTED
Dynavax Technologies
DVAX
-170,000
GBIO
305
DELISTED
Generation Bio
GBIO
-22,144
IDXX icon
306
Idexx Laboratories
IDXX
$44.5B
-400
IMUX icon
307
Immunic
IMUX
$204M
$0 ﹤0.01%
+3,000
NGNE icon
308
Neurogene
NGNE
$448M
-30,633
NVCR icon
309
NovoCure
NVCR
$1.97B
-34,000
OLMA icon
310
Olema Pharmaceuticals
OLMA
$1.15B
-81,399
OMER icon
311
Omeros
OMER
$799M
-25,000
OTLK icon
312
Outlook Therapeutics
OTLK
$108M
0
PLYM
313
DELISTED
Plymouth Industrial REIT
PLYM
-41,065
QNRX
314
Quoin Pharmaceuticals
QNRX
$10.2M
-58,230
RAPT
315
DELISTED
RAPT Therapeutics
RAPT
-509,679
VTYX
316
DELISTED
Ventyx Biosciences
VTYX
-81,600
XBI icon
317
State Street SPDR S&P Biotech ETF
XBI
$8.32B
0
DAY
318
DELISTED
Dayforce
DAY
-5,000
GUTS icon
319
Fractyl Health
GUTS
$128M
0
BBOT
320
BridgeBio Oncology
BBOT
$719M
-226,248
ZONE
321
CleanCore Solutions
ZONE
$6.36M
-521,980
AAM
322
DELISTED
AA Mission Acquisition Corp
AAM
-578,359
IVF
323
INVO Fertility Inc
IVF
$3.04M
-5,344
GRCE
324
Grace Therapeutics
GRCE
$39.8M
-641,988
CCCX
325
DELISTED
Churchill Capital Corp X
CCCX
-64,887